|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 26, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Subscription | |||||
| Advertising | |||||
| Other | |||||
| Affiliate, licensing and other | |||||
| Total revenues | |||||
| Operating costs | |||||
| Cost of revenue (excluding depreciation and amortization) | |||||
| Sales and marketing | |||||
| Product development | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Generative AI Litigation Costs | |||||
| Acquisition-related costs | |||||
| Impairment charge | |||||
| Impairment charges | |||||
| Multiemployer pension plan liability adjustments | |||||
| Lease termination charge | |||||
| Total operating costs | |||||
| Operating profit | |||||
| Other components of net periodic benefit (costs)/income | |||||
| Gain from joint ventures | |||||
| Interest income and other, net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Net income attributable to the noncontrolling interest | |||||
| Net income attributable to The New York Times Company common stockholders | |||||
| Average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Basic earnings per share attributable to The New York Times Company common stockholders (in USD per share) | |||||
| Diluted earnings per share attributable to The New York Times Company common stockholders (in USD per share) | |||||
| Dividends declared per share (in USD per share) | |||||
Loading...